Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: Analysis of 189 episodes

Archives of Internal Medicine

Volumn 156, Issue 18, 1996, Pages 2121-2126

  Vidal, Francesc ^a,b   Mensa, Josep ^c   Almela, Manuel ^c   Martínez, José Antonio ^c   Marco, Francesc ^c   Casals, Climent ^c   Gatell, Josep Maria ^c   Soriano, Eladio ^c   Jimenez De Anta, María Teresa ^c  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL TRIAL; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; TREATMENT OUTCOME;

AGED; BACTEREMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS;

EID: 0029909181     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.18.2121     Document Type: Article

References (34)

1. Pollack M. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennet's Principles and Practice of Infectious diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:1980-2003.
2. Flick MR, Cluff LE. Pseudomonas bacteremia: review of 108 cases. Am J Med. 1975;60:501-507.
3. Rittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital death. Arch Intern Med. 1995;155: 1177-1184.
4. Giamarellou H. Empiric therapy for infedions in the febrile, neutropenic, compromised host. Med Clin North Am. 1995;79:559-580.
5. Hilf M, Yu VL, Sharp JA, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87:540-546.
6. Bisbe J, Gatell JM, Puig J, et al. Pseudomonas aeruginosa bacterernia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis. 1988;10:629-635.
7. Gallagher PG, Watanakunakorn C. Pseudomonas bacteremia in a community teaching hospital, 1980-84. Rev Infect Dis. 1989;11:846-852.
8. Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, Richat H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis. 1994;170:377-383.
9. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med. 1985;145:1621-1629.
10. Gilardi GL. Pseudomonas. In: Lennette EH, Balows A, Hauser WJR, Shadomy HJ, eds. Manual of Clinical Microbiology. 4th ed. Washington, DC: American Society of Microbiology; 1985:350-372.
11. National Committee for Clinical and Laboratory Standards. Methods for the Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically. 2nd ed. Villanova, Pa: National Committee for Clinical and Laboratory Standards; 1990. Approved standard M7-A2.
12. Arbo MDJ, Snydman DR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med. 1994;154:2641-2645.
13. National Nosocomial Infections Study. Site Definitions Manual. Atlanta, Ga: Centers for Disease Control; 1972.
14. Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGrawHill International Book Co; 1994.
15. McCabe WR, Jackson CG. Gram-negative bacteremia, I: etiology and ecology. Arch Intern Med. 1962;110:847-855.
16. Perl TM, Dvorak LA, Hwang T, Wenzel RP. Long-term survival and function after suspected gram-negative sepsis. JAMA. 1995;274:338-345.
17. Fauci AS, Dale DC, Below JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations (NIH conference). Ann Intern Med. 1976;84: 304-315.
18. Young LS. Sepsis syndrome. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:690-705.
19. Buchanan GR. Approach to treatment of the febrile cancer patient with low-risk neutropenia. Hematol Oncol Clin North Am. 1993;7:919-935.
20. Schlesselman JJ. Case Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982.
21. Cox DR. Analysis of Binary Data. London, England: Chapman & Hall; 1970: 142.
22. Dixon WJ, Brown MB, Engelman L, et al. BMDP Statistical Software. Berkeley, Calif: University of California Press; 1985.
23. Nelson MR, Shanson DC, Barter JG, Hawkins DA, Gazzard BG. Pseudomonas septicaemia associated with HIV. AIDS. 1991;5:761-763.
24. Mendelson MH, Gurtman A, Szabo S, et al. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis. 1994;18:886-895.
25. Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis. 1992;14:403-411.
26. Baron AD, Hollander H. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis. 1993; 148:992-996.
27. Shepp DH, Tang ITL, Ramundo MB, Kaplan MH. Serious Pseudomonas aeruginosa infection in AIDS. J Acquit Immune Defic Syndr. 1994;7:823-831.
28. Fichtenbaum CJ, Woeltje KF, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis. 1994;19:417-422.
29. Rose HD, Heckman MG, Unger JD. Pseudomonas aeruginosa pneumonia in adults. Am Rev Respir Dis. 1973;107:416-422.
30. Pennington JE, Reynolds HY, Carbone PP. Pseudomonas pneumonia: a retrospective study of 36 cases. Am J Med. 1973;55:155-160.
31. Young LS. Fever and septicemia. In: Rubin RH, Young LS, eds. Clinical Approach to Infection in the Compromised Host. 3rd ed. New York, NY: Plenum Medical Book Co; 1994:67-104.
32. Mani S, Barry M, Concato J. Granulocyte - colony stimulating factor therapy in drug-induced agranulocytosis. Arch Intern Med. 1993;153:2500-2501.
33. Young NS. Agranulocytosis. JAMA. 1994;271:935-938.
34. Maher DW, Lieschke GJ, Green M, et al. Filgastrim in patients with chemotherapyinduced febrile neutropenia. Ann Intern Med. 1994;121:492-501.